Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma.

ABSTRACT:

Purpose

Adrenocortical carcinoma (ACC) is a rare and aggressive cancer, and no current effective therapy is available for locally advanced and metastatic ACC. Drug repurposing is an emerging approach for identifying new indications for existing drugs, especially for rare cancers such as ACC. The objective of this study was to use quantitative high-throughput screening to identify agents with antineoplastic activity against ACC.

Experimental design

A screening of 4,292 compounds was performed on three ACC cell lines: BD140A, SW-13, and NCI-H295R.

Results

Twenty-one active compounds were identified, with an efficacy of >80% in all three cell lines. Of these, niclosamide showed higher efficacy and lower IC50 than established anti-ACC drugs. We then validated niclosamide-

SUBMITTER: Satoh K 

PROVIDER: S-EPMC4947455 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature